Frustaci, A.; Verardo, R.; Scialla, R.; Bagnato, G.; Verardo, M.; Alfarano, M.; Russo, M.A.
Downregulation of Mannose-6-Phosphate Receptors in Fabry Disease Cardiomyopathy: A Potential Target for Enzyme Therapy Enhancement. J. Clin. Med. 2022, 11, 5440.
https://doi.org/10.3390/jcm11185440
AMA Style
Frustaci A, Verardo R, Scialla R, Bagnato G, Verardo M, Alfarano M, Russo MA.
Downregulation of Mannose-6-Phosphate Receptors in Fabry Disease Cardiomyopathy: A Potential Target for Enzyme Therapy Enhancement. Journal of Clinical Medicine. 2022; 11(18):5440.
https://doi.org/10.3390/jcm11185440
Chicago/Turabian Style
Frustaci, Andrea, Romina Verardo, Rossella Scialla, Giulia Bagnato, Margherita Verardo, Maria Alfarano, and Matteo A. Russo.
2022. "Downregulation of Mannose-6-Phosphate Receptors in Fabry Disease Cardiomyopathy: A Potential Target for Enzyme Therapy Enhancement" Journal of Clinical Medicine 11, no. 18: 5440.
https://doi.org/10.3390/jcm11185440
APA Style
Frustaci, A., Verardo, R., Scialla, R., Bagnato, G., Verardo, M., Alfarano, M., & Russo, M. A.
(2022). Downregulation of Mannose-6-Phosphate Receptors in Fabry Disease Cardiomyopathy: A Potential Target for Enzyme Therapy Enhancement. Journal of Clinical Medicine, 11(18), 5440.
https://doi.org/10.3390/jcm11185440